Bristol-Myers launches exchange offer for Celgene debt

|About: Bristol-Myers Squibb C... (BMY)|By:, SA News Editor

Bristol-Myers Squibb (NYSE:BMY) has initiated an exchange offer for outstanding Celgene (NASDAQ:CELG) debt for up to $19.85B of new debt to be issued by BMY and cash.

Last week, shareholders in both companies voted in favor of the merger.

Subscribe for full text news in your inbox